Therefore, we will focus in future studies on the role of different signalling pathways involved in the promotive effect of KDM5B on HCC through miR‐448–mediated effects on the YTHDF3/ITGA6 axis, aiming to identify new therapeutic targets for treating this disease. Here, YTHDF3 is linked to hepatocellular carcinoma.